NOD2 in Crohn's disease - Loss or gain of function mutations?

Netherlands Journal of Medicine

Volumn 63, Issue 8, 2005, Pages 286-287

  Zelinkova, Z ^a   Stokkers, P ^a   Hommes, D W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Crohn's disease; Cytokine; NOD2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; MURAMYL DIPEPTIDE;

CELL LINE; CROHN DISEASE; CYTOKINE PRODUCTION; EDITORIAL; GENE MUTATION; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANIMALS; CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

EID: 26044465072     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Netea MG, Ferwerda G, de Jong DJ, Girardin SE, Kullberg BJ, van der Meer JWM. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype. Neth J Med 2005;63:305-8.
2. Tanabe T, Chamaillard M, Ogura Y, Zhu L, Qiu S, Masumoto J et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 2004; 23(7):1587-97.
3. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278(8):5509-12.
4. Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5:800-8.
5. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307(5710):731-4.
6. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1β processing. Science 2005; 307(5710):734-8.
7. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003; 125:47-57.
8. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002; 277(44):41701-5.